Golvatinib, CAS [[928037-13-2]]

Produktübersicht

• Artikelname: Golvatinib, CAS [[928037-13-2]]
• Artikelnummer: BYT-ORB1300700
• Hersteller Artikelnummer: orb1300700
• Alternativnummer: BYT-ORB1300700-1, BYT-ORB1300700-1, BYT-ORB1300700-10, BYT-ORB1300700-100, BYT-ORB1300700-2, BYT-ORB1300700-25, BYT-ORB1300700-5, BYT-ORB1300700-50
• Hersteller: Biorbyt
• Kategorie: Biochemikalien
• Alternative Synonym: VEGFR, VEGFR2, Vascular endothelial growth factor receptor, E7050, E-7050, E 7050, c-Met/HGFR, cMet/HGFR, c-Met, cMet, inhibit, Golvatinib, Inhibitor, HGFR

Produktbeschreibung

Golvatinib (E-7050) is an orally active dual inhibitor targeting c-Met and VEGFR-2 tyrosine kinases, showing potential antineoplastic activity by suppressing tumor growth and angiogenesis. It has been investigated in preclinical studies for various cancers, including hepatocellular carcinoma and glioblastoma, in both in vitro and in vivo models.

Produkteigenschaften

• Molekulargewicht: 633.69
• Reinheit: 99.50% (May vary between batches)
• CAS Nummer: [928037-13-2]
• Formel: C33H37F2N7O4
• Target-Kategorie: VEGFR,c-Met/HGFR

Anwendungsbeschreibung

• Anwendungsbeschreibung: Solubility: H2O:< 1 mg/mL (insoluble or slightly soluble),Ethanol:< 1 mg/mL (insoluble or slightly soluble),DMSO:100 mg/mL (157.81 mM),10% DMSO+40% PEG300+5% Tween 80+45% Saline:4 mg/mL (6.31 mM)